Hester Biosciences informs about outcome of board meeting

29 Oct 2018 Evaluate

Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved, Unaudited Standalone Financial Results for the quarter and half year ended on 30 September, 2018, declared 2nd interim dividend of 20% that is INR 2.00 per equity share on the face value of INR 10 per share. The company has already paid 1st Interim Dividend of INR 2.00 per equity shares, and revision in remuneration of Rajiv Gandhi, CEO & Managing Director of the Company for the current tenure ending on 31 March 2020, subject to approval of Members.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1506.10 -11.60 (-0.76%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×